Skyrizi 150 mg Pre-Filled Syringe Guide
Quick summary: Skyrizi contains risankizumab and is used for moderate to severe plaque psoriasis and psoriatic arthritis. This guide explains how it works, how it is given, and what to check before use. Always...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Skyrizi contains risankizumab and is used for moderate to severe plaque psoriasis and psoriatic arthritis. This guide explains how it works, how it is given, and what to check before use.
Always follow the official patient leaflet and the advice of your healthcare professional for your own treatment plan.
Medical disclaimer: This article is for general information only. It does not replace medical advice, diagnosis, or the instructions in the product leaflet. If you have questions about your condition, injection technique, side effects, or suitability, speak with a doctor or pharmacist.
What is Skyrizi 150 mg solution for injection?
Skyrizi is an injectable medicine containing risankizumab. It is described in the source content as a treatment for moderate to severe plaque psoriasis and psoriatic arthritis.
This guide focuses on the 150 mg solution for injection in a pre-filled syringe and the key points patients commonly want to understand before use.
How does Skyrizi work?
Skyrizi is a monoclonal antibody that targets interleukin 23 (IL-23). By inhibiting IL-23, it helps reduce inflammation linked with autoimmune conditions such as psoriasis and psoriatic arthritis.
The original content describes this as a targeted approach that can help improve skin lesions and joint symptoms over time.
What are the main benefits described?
- Targeted therapy: It acts on IL-23 rather than broadly affecting the whole body.
- Skin improvement: The source content notes visible improvement in plaque psoriasis symptoms for many patients.
- Joint symptom relief: It may help reduce pain and stiffness in psoriatic arthritis.
- Convenient format: The pre-filled syringe is designed for injection use.
Clinical studies are mentioned in the source content as showing sustained benefit in some patients, but individual results can vary.
How is Skyrizi given?
The source content describes Skyrizi as a pre-filled syringe for injection. It also notes that patients should read the leaflet carefully and follow the prescribed schedule.
General handling points mentioned in the original text include allowing the syringe to reach room temperature before use and rotating injection sites to help reduce irritation.
General injection steps mentioned in the source content
- Read the patient information leaflet first.
- Wash your hands before handling the syringe.
- Allow the syringe to reach room temperature for about 30 minutes.
- Choose an injection site such as the thigh or abdomen.
- Clean the area before injection.
- Inject as instructed in the leaflet or by a healthcare professional.
- Dispose of the syringe safely after use.
Do not rely on this summary alone for technique. The official leaflet and professional training, if provided, are the best sources for exact administration instructions.
What should you check before using it?
Before using Skyrizi, it is sensible to confirm the following with a doctor, nurse, or pharmacist:
- That the medicine and strength match the prescription.
- How and when the injection should be given.
- How to store the syringe correctly.
- What to do if a dose is missed or delayed.
- Which symptoms should prompt medical advice.
Possible side effects mentioned in the source content
The original content lists the following possible side effects:
- Injection site reactions such as redness, swelling, or itching
- Headache
- Fatigue
- Allergic reactions, which can be serious in rare cases
It also notes that infections are an important safety consideration because Skyrizi affects the immune response.
When should you seek medical advice?
Contact a healthcare professional promptly if you notice unusual symptoms, signs of infection, or a possible allergic reaction. If you are unsure whether a symptom is related to the medicine, ask a pharmacist or doctor for guidance.
How much does Skyrizi cost?
The source content says the cost can vary depending on location, insurance coverage, and pharmacy pricing. It also states that the annual retail price may be around $6,000, although this can differ widely.
If cost is a concern, the original content suggests checking insurance coverage and asking about patient assistance options through official channels.
Where is Skyrizi available?
The source content says Skyrizi may be available through:
- Pharmacies with a valid prescription
- Licensed online pharmacies
- Hospital pharmacies
Always verify that any pharmacy is properly licensed and that the product matches the prescription.
Frequently asked questions
▸ Does Skyrizi come in a syringe?
Yes. The source content describes Skyrizi as available in a pre-filled syringe for injection.
▸ What conditions is Skyrizi used for?
The source content says it is used for moderate to severe plaque psoriasis and psoriatic arthritis.
▸ What is the active ingredient in Skyrizi?
The active ingredient is risankizumab.
▸ Can Skyrizi be injected cold?
The source content recommends allowing it to reach room temperature before injection to help reduce discomfort.
▸ Should injection sites be rotated?
Yes. The original content advises rotating injection sites to help reduce irritation.
Safety reminder
Use Skyrizi only as directed in the official leaflet and by your healthcare professional. Do not change your treatment plan on your own. If you are unsure about storage, injection technique, side effects, or whether the medicine is appropriate for you, ask a doctor or pharmacist.
Related questions about Skyrizi
What is Skyrizi solution?
Skyrizi solution is an injectable medicine containing risankizumab, which targets IL-23 and is described in the source content as helping reduce inflammation linked to psoriasis and psoriatic arthritis.
What are the options for Skyrizi injections?
The source content mainly refers to the pre-filled syringe. It also notes that administration may take place at home or in a healthcare setting, depending on advice and comfort level.
How should the syringe be handled before use?
The original content says to let it reach room temperature for about 30 minutes and to follow the leaflet carefully.
| Topic | What the source content says |
|---|---|
| Active ingredient | Risankizumab |
| Main target | Interleukin 23 (IL-23) |
| Form | Solution for injection in a pre-filled syringe |
| Conditions mentioned | Moderate to severe plaque psoriasis and psoriatic arthritis |
| Commonly mentioned side effects | Injection site reactions, headache, fatigue |
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.